Cargando…
Managing oncology clinical trials during COVID-19 pandemic
São Paulo city is the epicenter of the Brazilian COVID-19 pandemic. The Instituto do Cancer do Estado de São Paulo is currently conducting 161 multinational sponsored trials plus 116 in house studies in the oncologic population. There are 242 currently active participants and 180 patients in follow-...
Autores principales: | Arai, Roberto J., Moniz, Camila M.V., Chen, André T.C., Mak, Milena P., Chammas, Roger, Hoff, Paulo M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424329/ https://www.ncbi.nlm.nih.gov/pubmed/32835128 http://dx.doi.org/10.1016/j.conctc.2020.100637 |
Ejemplares similares
-
ICESP, a research hub within a total cancer care center
por: Chammas, Roger, et al.
Publicado: (2019) -
Tumors as complex organs: are cancers manageable through the modification of their microenvironment?
por: Chammas, Roger
Publicado: (2013) -
The use of biosimilar medicines in oncology - position statement of the Brazilian Society of Clinical Oncology (SBOC)
por: Fernandes, G.S., et al.
Publicado: (2018) -
Uro-oncologic patient management during the COVID-19 pandemic: survey findings from an Italian oncologic hub
por: Luzzago, Stefano, et al.
Publicado: (2021) -
Management of Gynaecological oncology diseases during COVID-19 global pandemic
por: de Andrade Vieira, Marcelo, et al.
Publicado: (2020)